Key facts
- It has raised $19.3M; the latest was Later Stage VC ($4.6M) in Apr 2026.
- Notable investors include European Commission, Bayern Kapital, Fil Rouge Capital, Vi Partners, AQAL Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for XO Life
- ·The full record, as it builds
Funding rounds
No funding rounds for XO Life are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About XO Life
Operator of a digital patient monitoring platform intended for patient education, patient engagement, support, and real-world patient insights in everyday care. The company's platform provides patient companionship as a service to pharma and medical technology companies as well as unique real-world insights into patient preferences and outcomes for all drugs, treatments, and diseases to increase adherence and improve customer loyalty, enabling patients to meet with pharma manufacturers for an improved life.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2016
- Employees
- 36
- Website
- xo-life.com/
- Ownership
- Privately Held (backing)
XO Life doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in XO Life shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on XO Life in its N-PORT filings yet. We sweep new filings monthly.